| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 06/22/2005 | EP1543034A2 Treatment and prophylaxis with 4-1bb-binding agents |
| 06/22/2005 | EP1542996A2 Octahydro-2-h-naphtho 1,2-f indole-4-carboxamide derivatives as selective glucocorticoid receptor modulators |
| 06/22/2005 | EP1542976A1 Substituted 4-(indazol-3-yl)phenols as estrogen receptor (er) ligands and their use in the treatment of inflammatory diseases |
| 06/22/2005 | EP1542719A2 Methods and compositions for control of bone formation via modulation of sympathetic tone |
| 06/22/2005 | EP1469856A4 8-heteroaryl xanthine adenosine a sb 2b /sb receptor antagonists |
| 06/22/2005 | EP1267915B1 Activated protein c for treating pancreatitis |
| 06/22/2005 | CN1630724A Compositions and methods for inhibiting expression of a target gene |
| 06/22/2005 | CN1630709A Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 06/22/2005 | CN1630516A Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 06/22/2005 | CN1630515A Compounds active at the glucocorticoid receptor II |
| 06/22/2005 | CN1630514A Methods and compositions for control of bone formation via modulation of sympathetic tone |
| 06/22/2005 | CN1629140A 3-cyano-1-alkoxy indole derivatives, preparing process and application thereof |
| 06/22/2005 | CN1628775A Wheat seeding powder for preventing and treating insulin resisting syndrome and its preparation process |
| 06/22/2005 | CN1207283C 4-aminopiperidine derivatives and their use as medicine |
| 06/22/2005 | CN1207047C Complex plant estrogen formulation which can delay female senility and method preparing same |
| 06/21/2005 | US6908935 Calcium receptor modulating agents |
| 06/21/2005 | US6908930 4-substituted 7-AZA-indolin-2-ones and their use as protein kinase inhibitors |
| 06/21/2005 | US6908897 At least one is a human or animal insulin analogue; coupled together with a diacid such as by reacting with suberic acid, bis(N-hydroxysuccinimidyl) ester |
| 06/21/2005 | US6908614 Anti-aging/menopause symptoms relief using ganoderma lucidum spores |
| 06/16/2005 | WO2004048565A9 Apoptosis-associated protein and use thereof |
| 06/16/2005 | US20050131236 Central nervous ystem disorders; neurodegenerative disorders; muscle contraction; endocrine diseases |
| 06/16/2005 | US20050131060 Spirolaxine acts as active principle for treatment of those pathologies responding to activation of PPAR gamma receptor, such as acute malignant haemopathies. and Type 2 insulin-resistant diabetes |
| 06/16/2005 | US20050131047 cardiovascular disorders |
| 06/16/2005 | US20050131005 4-azasteroid derivatives as androgen receptor modulators |
| 06/16/2005 | US20050130998 Central nervous ystem diorders; Alzheimer's disease ; anticancer agents |
| 06/16/2005 | US20050130900 Sustained release drug formulations containing a carrier peptide |
| 06/16/2005 | US20050130145 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, and agonists; drug screening |
| 06/16/2005 | US20050129667 treating leukemia or bone cancer by injecting a samarium comples of ethylenediaminetetramethanephosphonic acid and another chemotherapeutic agent; stem cell/bone marrow transplantation and/or restoration; patient is not subjected to total body irradiation |
| 06/16/2005 | CA2547759A1 Vanadium compounds as inhibitors of phosphatases |
| 06/15/2005 | EP1541560A1 Novel tetrahydroquinoline derivatives |
| 06/15/2005 | EP1541125A1 Spreadable compositions for topical use, a process of making same and uses thereof |
| 06/15/2005 | EP1539933A2 Methods of organ regeneration |
| 06/15/2005 | EP1539695A1 N-4-piperidinyl compounds as ccr5 modulators |
| 06/15/2005 | EP1539674A1 Amino-propanol derivatives |
| 06/15/2005 | EP1539662A1 Cannabinoid receptor ligands |
| 06/15/2005 | EP1539284A2 Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
| 06/15/2005 | EP1539217A2 Methods for identification of compounds modulating insulin resistance |
| 06/15/2005 | EP1539216A2 Labelled somatostatin analogs backbone cyclized through metal complexation |
| 06/15/2005 | EP1539205A1 Method for the preparation of phytoprogestogenic extracts from rhizoma ligusticum chuanxiong and uses thereof |
| 06/15/2005 | EP1538913A2 Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
| 06/15/2005 | EP1373240B1 Retinoid x receptor modulators |
| 06/15/2005 | EP1171121B1 Pharmaceutical compositions comprising dipeptidylpeptidase iv inhibitors for the promotion of growth |
| 06/15/2005 | CN1628125A Process for the production of 6.alpha.,9.alpha-difluoro-17.alpha.-(1-oxopropoxy-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17.beta.-carbothioic acid |
| 06/15/2005 | CN1626534A Steroid receptor modulator compounds and methods |
| 06/15/2005 | CN1626220A Chinese herbal medicine for treating hyperthyroidism |
| 06/15/2005 | CN1626095A Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol |
| 06/15/2005 | CN1206212C Tri-substd. phenyl derivs. and analogues |
| 06/15/2005 | CN1205994C Pulmonary delivery of active agents |
| 06/15/2005 | CN1205936C Novel contraceptive medicament and method for producing the same |
| 06/15/2005 | CN1205931C Pharmaeutical agent comprising benzamide derivative as active ingredient |
| 06/14/2005 | US6905855 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 06/14/2005 | US6905714 Method for modulating steroidogenic activity |
| 06/14/2005 | US6905688 Comprises therapeutic fusion proteins for diagnosis and treatment of cancers, neovascularization and autoimmune diseases |
| 06/14/2005 | US6905687 Fusion proteins; immunogens; solid phase synthesis; kits |
| 06/14/2005 | CA2346567C Method for preparing a solution for nasal spray containing sex hormones and a cyclodextrin |
| 06/09/2005 | US20050125846 Expression vector comprising nucleotide sequences coding transmembrant transport protein for use in diagnosis, treatment and prevention of thyroid disorders |
| 06/09/2005 | US20050124682 Such as N-{2-[5-(methylthio)-1H-indol-3-yl]ethyl}acetamide for treatment of disorders of the melatoninergic system; hormone replacement therapy |
| 06/09/2005 | US20050124537 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
| 06/09/2005 | US20050123634 Method for modulating steroidogenic activity |
| 06/09/2005 | US20050123633 Obtained by fermenting soybean germ, which is used as raw material, with koji mold, thus breaking down proteins, then hydrolyzing, extracting and concentrating using solvent to produce an isoflavone aglycone concentrate |
| 06/09/2005 | US20050123618 Method of producing micro-capsules for the sustained release of drugs |
| 06/09/2005 | US20050123576 Mupirocin compositions for topical use, an improved process of making same and methods of using same |
| 06/09/2005 | US20050123575 Heating, cooling, reheating and recooling a mixture containing hard fat while stirring; cosmetics, cosmeceutical, pharmaceutical; second temperature is lower than the congelation temperature of the mixture; hard fat is a mixture of triester of glycerin with caprylic, capric and stearic acids |
| 06/09/2005 | US20050123558 Modifeid polypeptide |
| 06/09/2005 | US20050123536 Treatment of immunological disorders using anti-dc30 antibodies |
| 06/09/2005 | CA2545473A1 Macromolecular drug complexes having improved stability and therapeutic use of the same |
| 06/09/2005 | CA2544480A1 Novel 8-(piperazine-1-yl)- and 8-([1,4]diazepan-1-yl)-xanthine, the production and use thereof in the from of a drug |
| 06/08/2005 | EP1537857A1 Mupirocin compositions for topical use, a process of making same and uses thereof |
| 06/08/2005 | EP1537138A2 Receptors and membrane-associated proteins |
| 06/08/2005 | EP1537114A1 Organic compounds as agents for the treatment of aldosterone mediated conditions |
| 06/08/2005 | EP1537113A1 Arylalkyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 06/08/2005 | EP1537073A2 Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands |
| 06/08/2005 | EP1536835A1 Liquid formulations with high concentration of human growth hormone (hgh) comprising phenol |
| 06/08/2005 | EP1536826A2 Thymus-based tolerogenic approaches for type i diabetes. |
| 06/08/2005 | EP1189895B1 Thiazole and oxazole derivatives and their pharmaceutical use |
| 06/08/2005 | EP1001797B1 Soya extract, process for its preparation and pharmaceutical composition |
| 06/08/2005 | CN1625569A Starch derivatives, starch active substance conjugates, method for the production thereof and their use as medicaments |
| 06/08/2005 | CN1625557A Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments |
| 06/08/2005 | CN1625406A Formulation containing (lyso-) phosphatidylserine for the prevention and treatment of stress states in warm-blooded animals |
| 06/08/2005 | CN1625404A Aldosterone receptor antagonist and alpha-adrenergic modulating agent combination therapy for prevention or treatment of cardiovascular conditions |
| 06/08/2005 | CN1205219C Unsaturated 14,15-cyclopropane-cendrostanes, a method for their production and pharmaceutical compositions containing these compounds |
| 06/08/2005 | CN1204924C Liquid composition of biodegradable block copolymer for drug delivery system and process for preparation thereof |
| 06/08/2005 | CN1204923C Anhydrous topical ski preparation |
| 06/08/2005 | CN1204911C Orally taken Chinese patent drug for treating endocrine dyscrasia |
| 06/07/2005 | US6903215 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/07/2005 | US6903187 Structural modification of clostridal neurotoxins including addition or deletion of a leucine-based motif to treat biological disorders include treating autonomic disorders, neuromuscular disorders and pain |
| 06/07/2005 | US6903186 Analogues of GLP-1 |
| 06/07/2005 | US6903132 Non-peptide GnRH agents, pharmaceutical compositions and methods for their use |
| 06/07/2005 | US6903115 Bipiperidine compounds |
| 06/07/2005 | US6903102 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 06/07/2005 | US6903091 Kidney diseases; hypotensive agents; blood disorders |
| 06/07/2005 | US6903087 Pyrido cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists |
| 06/07/2005 | US6902744 Exendin agonist formulations and methods of administration thereof |
| 06/07/2005 | US6902741 Laminates containing an active substance transdermal system |
| 06/07/2005 | US6902731 Transcription factors; for arterial administration via stent |
| 06/07/2005 | CA2281090C Sulfonamide compounds and salts for treatment of endothelin-mediated disorders |
| 06/02/2005 | US20050119321 2-substituted-1,3-thiazole compounds |
| 06/02/2005 | US20050119264 Tetrahydrobenzfluorene derivatives |
| 06/02/2005 | US20050119250 Amino-derivatives as novel inhibitors of histone deacetylase |
| 06/02/2005 | US20050119206 Cg8327, cg10823, cg18418, cg15862, cg3768, cg11447 and cg16750 homologous proteins involved in the regulation of energy homeostasis |